RPE65_HUMAN - dbPTM
RPE65_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RPE65_HUMAN
UniProt AC Q16518
Protein Name Retinoid isomerohydrolase
Gene Name RPE65
Organism Homo sapiens (Human).
Sequence Length 533
Subcellular Localization Cytoplasm . Cell membrane
Lipid-anchor . Microsome membrane . Attached to the membrane by a lipid anchor when palmitoylated (membrane form), soluble when unpalmitoylated. Undergoes light-dependent intracellular transport to become more concentrated
Protein Description Critical isomerohydrolase in the retinoid cycle involved in regeneration of 11-cis-retinal, the chromophore of rod and cone opsins. Catalyzes the cleavage and isomerization of all-trans-retinyl fatty acid esters to 11-cis-retinol which is further oxidized by 11-cis retinol dehydrogenase to 11-cis-retinal for use as visual chromophore. [PubMed: 16116091 Essential for the production of 11-cis retinal for both rod and cone photoreceptors]
Protein Sequence MSIQVEHPAGGYKKLFETVEELSSPLTAHVTGRIPLWLTGSLLRCGPGLFEVGSEPFYHLFDGQALLHKFDFKEGHVTYHRRFIRTDAYVRAMTEKRIVITEFGTCAFPDPCKNIFSRFFSYFRGVEVTDNALVNVYPVGEDYYACTETNFITKINPETLETIKQVDLCNYVSVNGATAHPHIENDGTVYNIGNCFGKNFSIAYNIVKIPPLQADKEDPISKSEIVVQFPCSDRFKPSYVHSFGLTPNYIVFVETPVKINLFKFLSSWSLWGANYMDCFESNETMGVWLHIADKKRKKYLNNKYRTSPFNLFHHINTYEDNGFLIVDLCCWKGFEFVYNYLYLANLRENWEEVKKNARKAPQPEVRRYVLPLNIDKADTGKNLVTLPNTTATAILCSDETIWLEPEVLFSGPRQAFEFPQINYQKYCGKPYTYAYGLGLNHFVPDRLCKLNVKTKETWVWQEPDSYPSEPIFVSHPDALEEDDGVVLSVVVSPGAGQKPAYLLILNAKDLSEVARAEVEINIPVTFHGLFKKS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MSIQVEHPA
------CCCEEECCC
23.02-
18PhosphorylationGYKKLFETVEELSSP
HHHHHHHHHHHHCCC
26.36-
78PhosphorylationDFKEGHVTYHRRFIR
CCCCCCEEEEEHHHH
14.1322210691
79PhosphorylationFKEGHVTYHRRFIRT
CCCCCEEEEEHHHHH
7.7022210691
89PhosphorylationRFIRTDAYVRAMTEK
HHHHHHHHHHHHHCC
8.0222817900
101PhosphorylationTEKRIVITEFGTCAF
HCCEEEEEECCCCCC
17.8622817900
105PhosphorylationIVITEFGTCAFPDPC
EEEEECCCCCCCCHH
13.1422817900
112S-palmitoylationTCAFPDPCKNIFSRF
CCCCCCHHHHHHHHH
7.4119049981
113AcetylationCAFPDPCKNIFSRFF
CCCCCHHHHHHHHHH
59.4719049981
117PhosphorylationDPCKNIFSRFFSYFR
CHHHHHHHHHHHHHC
25.1215557452
146S-palmitoylationVGEDYYACTETNFIT
CCCCEEEEECCCEEE
1.7230914787
231S-palmitoylationEIVVQFPCSDRFKPS
EEEEEEECCCCCCCC
7.5417122102
304PhosphorylationKKYLNNKYRTSPFNL
HHHHCCCCCCCCCCC
22.65-
329S-palmitoylationGFLIVDLCCWKGFEF
CEEEEEEECCCCHHH
1.9417122102
330S-palmitoylationFLIVDLCCWKGFEFV
EEEEEEECCCCHHHH
5.6717122102
376AcetylationVLPLNIDKADTGKNL
EEECCCCHHCCCCCC
44.3520167786
379PhosphorylationLNIDKADTGKNLVTL
CCCCHHCCCCCCEEC
55.72-
410PhosphorylationLEPEVLFSGPRQAFE
CCCEEEECCCCCCCC
43.6724719451

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RPE65_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RPE65_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RPE65_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
S27A1_HUMANSLC27A1physical
20356843
ZMYM2_HUMANZMYM2physical
28514442
TCPW_HUMANCCT6Bphysical
28514442
TCPG_HUMANCCT3physical
28514442

Drug and Disease Associations
Kegg Disease
H00527 Retinitis pigmentosa (RP)
H00837 Leber congenital amaurosis (LCR)
OMIM Disease
204100Leber congenital amaurosis 2 (LCA2)
613794Retinitis pigmentosa 20 (RP20)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RPE65_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Identification of a novel palmitylation site essential for membraneassociation and isomerohydrolase activity of RPE65.";
Takahashi Y., Moiseyev G., Ablonczy Z., Chen Y., Crouch R.K., Ma J.X.;
J. Biol. Chem. 284:3211-3218(2009).
Cited for: PROTEIN SEQUENCE OF 98-118, PHOSPHORYLATION AT THR-101; THR-105 ANDSER-117, PALMITOYLATION AT CYS-112, MUTAGENESIS OF CYS-106 ANDCYS-112, ACETYLATION AT LYS-113, AND MASS SPECTROMETRY.
Palmitoylation
ReferencePubMed
"Identification of a novel palmitylation site essential for membraneassociation and isomerohydrolase activity of RPE65.";
Takahashi Y., Moiseyev G., Ablonczy Z., Chen Y., Crouch R.K., Ma J.X.;
J. Biol. Chem. 284:3211-3218(2009).
Cited for: PROTEIN SEQUENCE OF 98-118, PHOSPHORYLATION AT THR-101; THR-105 ANDSER-117, PALMITOYLATION AT CYS-112, MUTAGENESIS OF CYS-106 ANDCYS-112, ACETYLATION AT LYS-113, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Identification of a novel palmitylation site essential for membraneassociation and isomerohydrolase activity of RPE65.";
Takahashi Y., Moiseyev G., Ablonczy Z., Chen Y., Crouch R.K., Ma J.X.;
J. Biol. Chem. 284:3211-3218(2009).
Cited for: PROTEIN SEQUENCE OF 98-118, PHOSPHORYLATION AT THR-101; THR-105 ANDSER-117, PALMITOYLATION AT CYS-112, MUTAGENESIS OF CYS-106 ANDCYS-112, ACETYLATION AT LYS-113, AND MASS SPECTROMETRY.

TOP